Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Juan Garcia Costa"'
Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure
Autor:
Francisco Rodriguez-Frias, Angelina Cañizares, Ángeles Castro-Iglesias, José A. Carrión, Juan Garcia Costa, Josep Quer, Damir Garcia-Cehic, Josep Gregori, Maria Buti, Ramiro Macenlle, Javier Pamplona, Carolina Campos, Juan Ignacio Esteban, Ariadna Rando, David Tabernero
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(9)
Direct-acting antivirals (DAAs) resolve chronic HCV infection in >95% of patients, but a small percentage do not respond to DAA-based therapy. These may be difficult to treat because of resistance-associated substitutions (RAS) emerging after treatme
Autor:
SONIA PEREZ CASTRO, Amparo Larrauri, Catherine Moore, Sylvie Van der WERF, Nuria Torner, Pedro Pechirra, FALCHI Alessandra, Bruno Lina, Lisa Domegan, Cathriona Kearns, Thea Kølsen Fischer, Maria Concepcion Delgado Sanz, Francisco Pozo, Simon De Lusignan, Lidia Brydak, Santiago Melón García, Ramona Trebbien, Inmaculada Casas, Richard Pebody, Silvia Jiménez-Jorge
Publikováno v:
Eurosurveillance
Eurosurveillance, 2018, 23 (5), ⟨10.2807/1560-7917.ES.2018.23.5.17-00284⟩
Eurosurveillance, 2018, 23 (5), ⟨10.2807/1560-7917.ES.2018.23.5.17-00284⟩
Respiratory syncytial virus (RSV) is considered the major pathogen causing severe lower respiratory tract infections among infants and young children [1]. RSV is the most common cause of hospitalisation for acute lower respiratory tract infection in